Advertisement.

BBIO Projected Dividend Yield

BridgeBio Pharma Inc ( NASDAQ : BBIO )

BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company focused on developing transformative medicines for genetic diseases and cancers with clear genetic drivers. Its pipeline includes Acoramidis (AG10) for amyloidosis TTR (ATTR), low-dose infigratinib for achondroplasia, Encaleret for Autosomal Dominant Hypocalcemia Type 1 (ADH1), and BBP-418 for LGMD2I (LGMDR9). The company's programs range from early science to advanced clinical trials, aiming to discover, create, test, and deliver these treatments to patients.

21 YEAR PERFORMANCE RESULTS

BBIO Dividend History Detail
BBIO Dividend News
BBIO Competitors News

# of Shares: 0

Closing Price: 28.12

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000